Dr. Miller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Clarkson Ave
# B4-333
Brooklyn, NY 11203Phone+1 718-270-4714Fax+1 718-270-1985
Summary
- I have focused on clinical care of children with sickle cell disease and participated in clinical research to better understand the pathophysiology, clinial course and complications and best treatments. A website regarding our program is at www.sicklecelldownstate.org; please visit and comment.
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 1979 - 1981
- Montefiore Medical Center/Albert Einstein College of MedicineResidency, Pediatrics, 1976 - 1979
- Albert Einstein College of MedicineClass of 1976
Certifications & Licensure
- FL State Medical License 2015 - 2017
- NY State Medical License 1978 - 2016
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Penicillin Prophylaxis in Sickle Cell Disease (PROPS) Start of enrollment: 1983 Aug 01
- Hydroxyurea to Prevent Organ Damage in Children With Sickle Cell Anemia Start of enrollment: 2000 Aug 01
- A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia Start of enrollment: 2010 May 01
- Join now to see all
Publications & Presentations
PubMed
- 1230 citationsCerebrovascular Accidents in Sickle Cell Disease: Rates and Risk FactorsKwaku Ohene-Frempong, Steven J. Weiner, Lynn A. Sleeper, Scott T. Miller, Stephen H. Embury
Blood. 1998-01-01 - 538 citationsHydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)Winfred C. Wang, Russell E. Ware, Scott T. Miller, Rathi V. Iyer, James F. Casella
Lancet. 2011-05-14 - 185 citationsImpact of hydroxyurea on clinical events in the BABY HUG trialCourtney D. Thornburg, Beatrice Files, Zhaoyu Luo, Scott T. Miller, Ram Kalpatthi
Blood. 2012-11-22
Journal Articles
- Magnetic Resonance Imaging/angiography and Transcranial Doppler Velocities in Sickle Cell Anemia: Results from the SWiTCH TrialHelton KJ, Adams RJ, Kesler KL, Lockhart A, Aygun B, Driscoll C, Heeney MM, Jackson SM, Krishnamurti L, Miller ST, Sarnaik SA, Schultz WH, Ware RE, Blood, 6/9/2014
- Pain and Other Non-neurological Adverse Events in Children with Sickle Cell Anemia and Previous Stroke Who Received Hydroxyurea and Phlebotomy or Chronic Transfusions ...Alvarez O, Yovetich NA, Scott JP, Owen W, Miller ST, Schultz W, Lockhart A, Aygun B, Flanagan J, Bonner M, Mueller BU, Ware RE; for the Investigators of the Stroke Wit..., Am J Hematol, 11/1/2013
- Red Blood Cell Alloimmunization in Sickle Cell Disease: Prevalence in 2010Miller ST, Kim H, Weiner DL, Wager CG, Gallagher D, Styles LA, Dampier CD, Roseff SD, for the Investigators of the Sickle Cell Disease Clinical Research Network (SCDCRN), Transfusion, 4/1/2013
- Join now to see all
Books/Book Chapters
Other
- Re: A Strong Case for Hydroxyurea for Young Children with Sickle Cell Disease: Are We There Yet?Thornburg CD, Lou Z, Miller S, Alvarez O, Thompson B, Ware R, Wang W, BABY HUG Investigators
http://bloodjournal.hematologylibrary.org/content/120/22/4304/reply#bloodjournal_el_7492
2/22/2013
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: